GENESEGUES INC has a total of 38 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2001. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and micro-structure and nano-technology are SOLVAY ANIMAL HEALTH INC, NORDEN LAB INC and PHILIPS ROXANE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Australia | 5 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | China | 3 | |
#6 | Canada | 2 | |
#7 | Singapore | 2 | |
#8 | Israel | 1 | |
#9 | Japan | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Micro-structure and nano-technology | |
#4 | Chemical engineering | |
#5 | Machines | |
#6 | Medical technology | |
#7 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Unger Gretchen M | 31 |
#2 | Lundell Beverly | 4 |
#3 | Unger Gretchen | 4 |
#4 | Unger G M | 1 |
#5 | Gretchen M Unger | 1 |
Publication | Filing date | Title |
---|---|---|
US2017247253A1 | Nanoparticles for Use in Medical and Research Applications | |
CA2959660A1 | Therapeutic nanoparticles and related compositions, methods, and systems | |
WO2008157514A2 | Metal ion-treated biocompatible polymers useful for nanoparticles | |
US2011269813A1 | Gene Silencing by Single-Stranded Polynucleotides | |
WO03087323A2 | Biologic modulations with nanoparticles | |
MXPA02008361A | Nanocapsule encapsulation system and method. |